key: cord-0845730-yniw94lj authors: Sebastião, Cruz S.; Galangue, Manuela; Gaston, Celestina; Van‐Dunen, Rui; Jandondo, Domingos; Neto, Zoraima; de Vasconcelos, Jocelyne Neto; Morais, Joana title: Serological identification of past and recent SARS‐CoV‐2 infection through antibody screening in Luanda, Angola date: 2021-05-06 journal: Health Sci Rep DOI: 10.1002/hsr2.280 sha: ef4e5deb939cd4df71847ad05138419e668e3ec1 doc_id: 845730 cord_uid: yniw94lj nan Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in China and spread to the world. 1 Pneumonia caused by SARS-CoV-2 was named coronavirus disease 2019 (COVID-19) and is currently a public health concern. 2,3 From December 2019 to December 2020, more than 60.1 million cases of infection and 1.4 million deaths, have been reported worldwide. 4 Until December 2020, the Ministry of Health of Angola reported more than 15 000 cases and 345 deaths. 4 The timely diagnosis of SARS-CoV-2 infection is fundamental to ensure controlling of the COVID-19 pandemic, the provision of treatment, and to avoid the worsening of the disease. [5] [6] [7] In practice, RT-PCR is the only way to confirm the SARS-CoV-2. 8 There are individuals that despite being epidemiologically related and presenting pulmonary radiological findings compatible with SARS-CoV-2, remain RT-PCR negative. 9 Factors such as the sample collecting and processing procedure may affect the result of the PCR assay. 10 Also, RT-PCR does not distinguish virus with active replication from residual RNA, which could cause false results, especially in asymptomatic individuals. 10 Therefore, serologic tests offer an alternative to assess the degree of exposure amongst different population groups. 11 There are no published studies that assessed the rate of exposure and immune response to SARS-CoV-2 in Luanda, the capital city of Angola. Herein, we used serological assay to screen IgM and IgG antibodies against SARS-CoV-2 in individuals from Luanda, to support the Ministry of Health of Angola in the management of the COVID-19. This was a cross-sectional study carried out with 660 individuals screened for antibodies against SARS-CoV-2 between July and September 2020 at Instituto Nacional de Investigação em Saúde (INIS), located in Luanda, the capital city of Angola. The INIS is a public institution of the Ministry of Health of Angola, which has as its main objective, to develop scientific research on health and its determinants for strengthening public health policies. The research team collected sociodemographic data through a standardized questionnaire in all individuals who freely agreed to participate in the investigation. The study was approved by the National Ethics Committee of Angola (nr.25/2020). Besides that, participants or legal guardians of each minor were informed of the study, and verbal consent was obtained before being included in the study. An estimate of 5 ml of whole blood was collected from each participant in a tube with a clot activator. Then, the tubes containing the blood samples were centrifuged and human serum aliquoted and stored between 2 and 8 C. The blood sample preparation was The statistical analysis was conducted using SPSS v25 (IBM SPSS Statistics). The frequencies and percentages are presented in the descriptive analysis. Mean and the SD was presented for normal distribution data. All categorical variables were dichotomized and analyzed with the chi-square (X 2 ) test and logistic regression. Moreover, odds ratio (OR), adjusted odds ratio (AOR), and their 95% confidence intervals (CIs) were also calculated to check interactions between categorical variables. The P value was deemed significant when P < .05. The sociodemographic characteristics and identification of SARS-CoV-2 by antibody test are summarized in Table 1 Of the 660 individuals screened for antibody against SARS-CoV-2, This study demonstrated that SARS-CoV-2 has induced antibody responses in COVID-19 patients from Angola. Previous studies have shown that the seroconversion and the levels of antibodies increase during the first 2 weeks and that seropositivity is 50% until the 11th day and 100% on the 39th day after the infection. 10 Total antibodies are the first to be detected, followed by the IgM and IgG antibodies. 10 Our study showed that about 1.1% and 2.3% of the studied population were exposed to SARS-CoV-2 and had IgG and IgM antibodies, respectively (Table 1) . These results indicate a low rate of exposure to SARS-CoV-2 and that exposed individuals in Angola, could be identi- A novel coronavirus from patients with pneumonia in China A pneumonia outbreak associated with a new coronavirus of probable bat origin The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 World Health Organization. 2020 COVID-19 Weekly Epidemiological Update Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical characteristics of coronavirus disease 2019 in China Laboratory diagnosis and monitoring the viral shedding of SARS-CoV-2 infection. The Innovation A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 Serological assays for severe acute respiratory syndrome Instructions for use for Detection Kit for 2019 Novel Coronavirus (2019-nCoV) RNA (PCR-Fluorescence Probing) Pandemia da COVID-19 em Angola Serological identification of past and recent SARS-CoV-2 infection through antibody screening in Luanda The authors confirm that the data supporting the findings of this study are available within the article. The lead author Cruz S. Sebastião affirms that no important aspects of the study have been omitted. https://orcid.org/0000-0003-1232-0119